{"id":"W4386272424","doi":"10.1159/000532064","title":"An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid","year":2023,"lang":"en","type":"article","venue":"Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tofacitinib; Keloid; Medicine; Janus kinase inhibitor; Janus kinase; Dermatology; Pharmacology; Fibroblast; Internal medicine; Wound healing; Lesion; Surgery; Cytokine; Rheumatoid arthritis; In vitro; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048923,0.001075522,0.002058803,0.0003057643,0.0005294262,0.0005101779,0.0005475346,0.0008596727,0.003792292],"category_scores_gemma":[0.0006455182,0.0003596866,0.00104284,0.0003448724,0.001020174,0.0008093516,0.0002518369,0.001399569,0.0004236733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009017542,"about_ca_system_score_gemma":0.001673842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001359796,"about_ca_topic_score_gemma":0.003830789,"domain_scores_codex":[0.9997169,0.00008968884,0.00001988363,0.00006517085,0.00003115231,0.00007716715],"domain_scores_gemma":[0.9996259,0.00006278256,0.00006832756,0.00003385051,0.00003023747,0.000178827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8811691,0.03333595,0.009927044,0.001199258,0.001691205,0.0004441183,0.0003533453,0.0007413367,0.02038035,0.0001885986,0.00159358,0.0489761],"study_design_scores_gemma":[0.6848658,0.2864477,0.02288023,0.00003910256,0.0009641772,0.0002085157,0.0001402599,0.001110161,0.001623802,0.0002089671,0.001467847,0.00004353844],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961441,0.00141706,0.0002128831,0.0001943973,0.00008578121,0.00100888,0.0002330361,0.00002572057,0.0006782201],"genre_scores_gemma":[0.9958518,0.0006876509,0.0004839622,0.0003811447,0.00009513589,0.001169557,0.0003230217,0.000004483181,0.001003248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003792292,"threshold_uncertainty_score":0.01268643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0854167968144067,"score_gpt":0.4213424748726338,"score_spread":0.3359256780582272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}